Roswell Park Cancer Institute — Buffalo, New York

Roswell Park Cancer Institute is a clinical research site located in Buffalo, New York, United States 14203.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Institute has participated in 1577 clinical trials with 410 currently active.

Therapeutic areas: Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Colorectal Cancer.

Sponsors: Regeneron Pharmaceuticals, Alliance for Clinical Trials in Oncology, Roswell Park Cancer Institute.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Institute?

Roswell Park Cancer Institute has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Institute conducted?

Roswell Park Cancer Institute has 1577 clinical trials on record, with 410 currently active. Their work covers Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Colorectal Cancer.

Is Roswell Park Cancer Institute accredited by Crixeo Health?

Roswell Park Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.